Who
Gary B. Gordon
Director
Company insider
Files Form 4 as: Director, TriSalus Life Sciences; Chief Medical Officer, Old Ayala.
In numbers
- Trades disclosed
- 27
- Buys
- 2
- Sells
- 2
- Bought
- $129K
- Sold
- $97K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 4 Jan 2021
- Last trade
- 15 May 2026
- Last filed
- 18 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 May 2026filed 18 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Bought | $25K10,000 at $2.46 | filing |
| 15 May 2026filed 18 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Bought | $25K10,000 at $2.46 | filing |
| 14 May 2026filed 15 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | —28,201 at $0.00 | filing |
| 14 May 2026filed 15 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | —24,553 at $0.00 | filing |
| 14 May 2026filed 15 May 2026 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —56,403 at $0.00 | filing |
| 14 May 2026filed 15 May 2026 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —56,403 at $0.00 | filing |
| 14 May 2026filed 15 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | —28,201 at $0.00 | filing |
| 14 May 2026filed 15 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | —24,553 at $0.00 | filing |
| 23 Feb 2026filed 23 Feb 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Bought | $40K9,756 at $4.10 | filing |
| 23 Feb 2026filed 23 Feb 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Bought | $40K9,756 at $4.10 | filing |
| 12 Jun 2025filed 27 Jun 2025 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 29 Jan 2025filed 31 Jan 2025 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 29 Jan 2025filed 31 Jan 2025 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 19 Jan 2023filed 23 Jan 2023 | Old Ayalaoption or derivative | SEC FORM 4 Code D | —89,000 | filing |
| 19 Jan 2023filed 23 Jan 2023 | Old Ayalaoption or derivative | SEC FORM 4 Code D | —19,170 | filing |
| 19 Jan 2023filed 23 Jan 2023 | Old Ayalaoption or derivative | SEC FORM 4 Code D | —31,950 | filing |
| 19 Jan 2023filed 23 Jan 2023 | Old Ayala | SEC FORM 4 Code D | —58,520 | filing |
| 16 May 2022filed 16 May 2022 | Ayala Pharmaceuticals | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 3 Jan 2022filed 5 Jan 2022 | Ayala Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —31,950 at $0.00 | filing |
| 24 Feb 2021filed 26 Feb 2021 | Ayala Pharmaceuticals | SEC FORM 4 Code M | $15K3,000 at $5.16 | filing |
News
Reviewing TriSalus Life Sciences (NASDAQ:TLSI) and Brainsway (NASDAQ:BWAY)TLSI · themarketsdaily.com · 21 Oct 2026Financial Comparison: Brainsway (NASDAQ:BWAY) and TriSalus Life Sciences (NASDAQ:TLSI)TLSI · dailypolitical.com · 14 Oct 2026TriSalus Life Sciences, Inc. (TLSI) – What Are Brokerages Saying About This Stock?TLSI · dailypolitical.com · 11 Oct 2026
0 headlines in the last 90 days name Gary B. Gordon; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.